Navigation Links
Engineered microbes grow in the dark
Date:5/19/2013

Scientists at the University of California, Davis have engineered a strain of photosynthetic cyanobacteria to grow without the need for light. They report their findings today at the 113th General Meeting of the American Society for Microbiology.

"In this work, we used synthetic biology approaches to probe and rewire photoautotrophic (exclusively relying on carbon dioxide and light energy for growth) cyanobacterial metabolism for the ability to grow without light energy," says Jordan McEwen, the lead researcher on the study. He is part of Shota Atsumi's lab at the university, a research group focused on developing synthetic organisms capable of converting carbon dioxide directly to biofuels.

The cyanobacterium strain Synechococcus elongatus strain PCC 7942 has been well characterized as a model photoautotroph. Previous work by Atsumi's lab has engineered this organism to recycle carbon dioxide into a variety of biofuels and valuable chemicals in the presence of light. Any cost-effective, cyanobacterial biofuel production scheme would use natural lighting conditions, limiting how much biofuel could be produced in a 24-hour period.

"To overcome this constraint, we installed foreign genes into S. elongatus to allow this cyanobacterium to grow and generate biofuels in diurnal (light or dark) conditions," says McEwen. "With recent, increased focus on cyanobacteria-based industrial applications, this advancement is desirable for more efficient, economical and controllable bioproduction systems."


'/>"/>

Contact: Jim Sliwa
jsliwa@asmusa.org
202-942-9297
American Society for Microbiology
Source:Eurekalert

Page: 1

Related biology news :

1. Europe needs genetically engineered crops, scientists say
2. Recruiting engineered cells to work for warfighters
3. Market Analysis: Biomaterials and Engineered Protein
4. Painting with catalysts: Nano-engineered materials for detoxifying water by use of sunlight
5. Engineered bacteria make fuel from sunlight
6. Production of 5-aminovaleric and glutaric acid by metabolically engineered microorganism
7. Engineered immune cells produce complete response in child with an aggressive pediatric leukemia
8. Leukemia patients remain in remission more than 2 years after engineered T cell therapy
9. Bioengineered marine algae expands environments where biofuels can be produced
10. Soft Robotics: A groundbreaking new journal on engineered soft devices that Interact with Living Systems
11. Engineered bacteria can make the ultimate sacrifice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2015)... 2015  Australia,s market for wearable technologies is considered ... the advent of several trials and prototypes. The release ... expected to ignite interest in wearables as well as ... . This in turn will spur greater innovation ... partnerships amongst vendors and distributors. Photo ...
(Date:5/20/2015)... , May 20, 2015 ... ) has announced the addition of ... Global Iris Recognition Market"  report to ... ,This research service analyses trends in ... government and commercial sectors, globally. Despite ...
(Date:5/18/2015)... GOTHENBURG, Sweden , May 18, 2015 ... touch fingerprint sensors FPC1020, FPC1025, FPC1145, FPC1155 and FPC1035 from ... place from June until and including Q3 2015 and the ... Asia . Communicated order values for 2015 hereby amount ... revenues for Q1 2015 of 140 MSEK and a number ...
Breaking Biology News(10 mins):Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 2Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 3Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 4Global Iris Recognition Market Report 2015 - 5-Year Opportunity Analysis 2Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2
... release is available in German . 48 healthy ... at the start of the experiment, the other half a placebo. ... situations in the form of a crying child, a girl hugging ... invited to express the depth of feeling they experienced for the ...
... skin crawla bug that crawls onto your lips while you ... bites, then gorges on your blood. And if that,s not ... a potentially deadly disease. Now Jean-Paul Paluzzi, a ... believes that manipulating physiology to prevent the insects from leaving ...
... an effective way of tackling global warming despite emitting small ... Research led by the University of Edinburgh suggests that ... the Earth,s emissions of methane which is considered to be ... warming. The results contrast with a previous scientific study ...
Cached Biology News:Hormone spray improves male sensitivity 2The kiss of death: Research targets lethal disease spread by insect that bites lips 2
(Date:6/1/2015)... Hutchison China MediTech Limited ... (publ) ("AstraZeneca"), Hutchison MediPharma Limited,s ("HMP") collaboration partner, ... clinical trial of HMP,s c-Met inhibitor savolitinib (AZD6094) ... cell lung cancer ("NSCLC"). AZD9291 is ... receptor (EGFR). Preliminary data on the activity of ...
(Date:5/31/2015)... June 1, 2015 Sobi, ... diseases, has selected Veeva Commercial Cloud to support ... medical. A complete solution, Veeva Commercial Cloud ... compliant content to provide a comprehensive view of ...      (Logo: http://photos.prnewswire.com/prnh/20120425/527164) , ...
(Date:5/31/2015)... , May 31, 2015 Halozyme ... company developing novel oncology and drug-delivery therapies, today ... clinical study of its investigational new drug PEGPH20 ... pancreatic cancer. The encouraging interim data ... Clinical Oncology annual meeting in an oral presentation ...
(Date:5/30/2015)... May 30, 2015 The Cholangiocarcinoma ... research for bile duct cancer, announced today the ... Fellowship Program. , The Foundation has ... throughout the country to raise awareness about cholangiocarcinoma ... support research that opens new pathways for diagnosis ...
Breaking Biology Technology:Savolitinib (AZD6094) Preliminary Phase Ib Clinical Data in Lung Cancer Presented at the 2015 ASCO Annual Meeting 2Savolitinib (AZD6094) Preliminary Phase Ib Clinical Data in Lung Cancer Presented at the 2015 ASCO Annual Meeting 3Sobi Establishes Global Commercial Operations in the Cloud with Best-in-Class Veeva Commercial Cloud 2Sobi Establishes Global Commercial Operations in the Cloud with Best-in-Class Veeva Commercial Cloud 3Halozyme Phase 2 Clinical Study Of Investigational Drug PEGPH20 Shows Doubling Of Progression-free Survival And Improvement Trend In Overall Survival In High HA Metastatic Pancreatic Cancer Patients 2Halozyme Phase 2 Clinical Study Of Investigational Drug PEGPH20 Shows Doubling Of Progression-free Survival And Improvement Trend In Overall Survival In High HA Metastatic Pancreatic Cancer Patients 3Halozyme Phase 2 Clinical Study Of Investigational Drug PEGPH20 Shows Doubling Of Progression-free Survival And Improvement Trend In Overall Survival In High HA Metastatic Pancreatic Cancer Patients 4Halozyme Phase 2 Clinical Study Of Investigational Drug PEGPH20 Shows Doubling Of Progression-free Survival And Improvement Trend In Overall Survival In High HA Metastatic Pancreatic Cancer Patients 5The Cholangiocarcinoma Foundation Awards $260,000 in Research Grants 2The Cholangiocarcinoma Foundation Awards $260,000 in Research Grants 3
... , ... marks the increasing popularity of open source software (OSS) in clinical trial electronic data ... ... OpenClinica, the rapidly growing open source clinical trial software, will gather on March 22nd, ...
... ... biopharmaceutical company focused on the development of novel vaccine candidates to treat chronic viral ... conference and will be attending the J.P. Morgan Healthcare Conference in San Francisco. ... Baltimore, MD (Vocus) ...
... ... QT Beat-to-Beat(sm) to Improve Precision and Reduce Risk of False Positives/Negatives , ... Rochester, New York (PRWEB) January ... and QT analysis, announced today that a leading global CRO has selected iCardiac as ...
Cached Biology Technology:OpenClinica Global Conference to Bring Together Global Community for Open Source Clinical Trials Software 2OpenClinica Global Conference to Bring Together Global Community for Open Source Clinical Trials Software 3OpenClinica Global Conference to Bring Together Global Community for Open Source Clinical Trials Software 4Profectus Biosciences to Present at Key Investor Conference in January 2010 2Profectus Biosciences to Present at Key Investor Conference in January 2010 3Leading Global CRO Selects iCardiac as Preferred Vendor 2
Tracker Datamatrix TRxD reads any 1D and 2D barcodes within 0.5 seconds....
Complete cell culture media with cytokines...
... BioChain's monkey normal multiple tissue ... specific cellular localization of genes or ... tissues. Tissues are mounted on positively ... Blots are available in the identical ...
8 different frozen tissues are mounted on positively charged glass slides...
Biology Products: